We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+15.03%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$13.8M
Cap. Flow
-$191K
Cap. Flow %
-0.17%
Top 10 Hldgs %
20.9%
Holding
65
New
2
Increased
55
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$1.91M
2
O icon
Realty Income
O
+$630K
3
CI icon
Cigna
CI
+$254K
4
GILD icon
Gilead Sciences
GILD
+$64.5K
5
MRK icon
Merck
MRK
+$63.4K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.93M
2
STOR
STORE Capital Corporation
STOR
+$1.24M
3
WBA
Walgreens Boots Alliance
WBA
+$1.21M
4
AFL icon
Aflac
AFL
+$372K
5
AMGN icon
Amgen
AMGN
+$291K

Sector Composition

Rank Sector Weight
1 Financials 21.34%
2 Healthcare 18.18%
3 Industrials 10.72%
4 Energy 10.01%
5 Technology 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$165B
$2.58M 2.28%
30,104
+815
+3% +$64.5K
MET icon
2
MetLife
MET
$62.4B
$2.4M 2.11%
33,099
+837
+3% +$60K
AMP icon
3
Ameriprise Financial
AMP
$47.8B
$2.37M 2.09%
7,619
+194
+3% +$59.2K
NXST icon
4
Nexstar Media Group
NXST
$6.01B
$2.37M 2.08%
13,513
+344
+3% +$60.4K
OGE icon
5
OGE Energy
OGE
$9.87B
$2.35M 2.07%
59,378
+1,508
+3% +$57.2K
CVX icon
6
Chevron
CVX
$382B
$2.33M 2.06%
13,009
-861
-6% -$150K
AFL icon
7
Aflac
AFL
$65.5B
$2.33M 2.06%
32,436
-5,558
-15% -$372K
ABBV icon
8
AbbVie
ABBV
$465B
$2.33M 2.05%
14,417
+363
+3% +$55.7K
GPC icon
9
Genuine Parts
GPC
$17.9B
$2.33M 2.05%
13,400
-1,075
-7% -$187K
PSX icon
10
Phillips 66
PSX
$82.9B
$2.32M 2.05%
22,332
+568
+3% +$58.1K
MRK icon
11
Merck
MRK
$322B
$2.31M 2.04%
20,830
+620
+3% +$63.4K
UL icon
12
Unilever
UL
$142B
$2.29M 2.02%
40,512
+1,030
+3% +$55.1K
SCHW
13
Charles Schwab
SCHW
$182B
$2.27M 2%
27,304
+703
+3% +$54.6K
DGX icon
14
Quest Diagnostics
DGX
$26B
$2.27M 2%
14,508
+368
+3% +$52.9K
AMGN icon
15
Amgen
AMGN
$209B
$2.26M 1.99%
8,611
-1,086
-11% -$291K
EOG icon
16
EOG Resources
EOG
$77.7B
$2.24M 1.97%
17,285
+438
+3% +$58.3K
LMT icon
17
Lockheed Martin
LMT
$131B
$2.16M 1.91%
4,444
+111
+3% +$51.6K
ITW icon
18
Illinois Tool Works
ITW
$84.1B
$2.16M 1.9%
9,788
+250
+3% +$53.2K
AES icon
19
AES
AES
$10.6B
$2.14M 1.89%
74,413
+1,922
+3% +$51.8K
PFG icon
20
Principal Financial Group
PFG
$24.3B
$2.12M 1.87%
25,289
+656
+3% +$56.3K
O icon
21
Realty Income
O
$61.1B
$2.12M 1.87%
33,366
+10,150
+44% +$630K
SNA icon
22
Snap-on
SNA
$21.5B
$2.11M 1.86%
9,254
+234
+3% +$52.9K
GD icon
23
General Dynamics
GD
$103B
$2.11M 1.86%
8,513
+216
+3% +$52.7K
AVGO icon
24
Broadcom
AVGO
$1.76T
$2.11M 1.86%
37,760
+950
+3% +$47.6K
SJM icon
25
J.M. Smucker
SJM
$13.5B
$2.04M 1.8%
12,877
+308
+2% +$45.9K
1
2 3

Similar funds

EW
Expressive Wealth Chicago, Illinois $105M AUM
ANBOT
American National Bank of Texas Richardson, Texas $105M AUM
P
Palladiem Bryn Mawr, Pennsylvania $105M AUM
SPW
Signet Private Wealth Chicago, Illinois $105M AUM
SHF
Safe Harbor Fiduciary Pensacola, Florida $105M AUM
NS
Northland Securities Minneapolis, Minnesota $105M AUM
ACA
Alpha Capital Advisors Bangor, Maine $105M AUM
HA
Helium Advisors Everett, Washington $105M AUM 15.41% 1-Year Est. Return

Weaver C. Barksdale & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Weaver C. Barksdale & Associates held 65 positions worth $113M, up 14% from $99.7M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Weaver C. Barksdale & Associates's Q4 2022 filing shows 2 new, 55 increased, 5 reduced and 3 closed positions. Its largest new stake was Crown Castle: 14,155 shares worth $1.92M. The largest sale was Apple, an estimated $1.93M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q4 2022 buy was Crown Castle: 14,155 shares worth $1.92M.
  • Weaver C. Barksdale & Associates added most to Realty Income in Q4 2022, an estimated $630K increase.
  • Weaver C. Barksdale & Associates's biggest Q4 2022 reduction was Aflac, cutting an estimated $372K.
  • Weaver C. Barksdale & Associates fully exited Apple in Q4 2022, selling an estimated $1.93M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $113M portfolio in Q4 2022.
  • Weaver C. Barksdale & Associates opened 2 new positions and closed 3 in Q4 2022.
  • Weaver C. Barksdale & Associates's portfolio value rose 14% quarter-over-quarter to $113M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2022, filed 14 Feb 2023.